Bin Li
GROUP
2019:
1. Zhang, Y., Zhang X., Zeng, C., Li, B., Zhang, C.., Li, W., Hou, X., Dong, Y.. Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR). Bioorg. Med. Chem. 27, 2187-2191 (2019). (IF 2.802) PDF
Publications before 2019:
1. Li, B., Zhao, W., Luo, X., Zhang, X., Li, C., Zeng, C., and Dong, Y. Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiency. Nat. Biomed. Eng. 1, 0066 (2017). (IF 17.135) PDF
2. Li, B., Zeng, C., and Dong, Y. Design and assessment of engineered CRISPR–Cpf1 and its use for genome editing. Nat. Protoc. 13, 899–914 (2018). (IF 11.334) PDF
3. Jiang, C., Mei, M., Li, B. (Co-first author), Zhu, X., Zu, W., Tian, Y ., Wang, Q., Guo, Y ., Dong, Y ., and Tan, X. A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo. Cell Research 27, 440–443 (2017). (IF 17.848) PDF
4. Li, B., Luo, X., Deng, B., Wang, J., McComb, D.W., Shi, Y ., Gaensler, K.M., Tan, X., Dunn, A.L., Kerlin, B.A., and Dong, Y. An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo. Nano Lett. 15, 8099–8107 (2015). (IF 12.279) PDF
5. Li, B., Zeng, C., Zhang, X., Luo, X., Zhao, W., Zhang, C., and Dong, Y. Synthetic oligonucleotides inhibit CRISPR-Cpf1 mediated genome editing. Cell Rep. 25, 3262–3272 (2018). (IF 7.815) PDF
6. Zhang, X., Li, B. (Co-first author), Luo, X., Zhao, W., Jiang, J., Zhang, C., Gao, M., Chen, X., and Dong, Y. Biodegradable amino-ester nanomaterials for Cas9 mRNA delivery in vitro and in vivo. ACS Appl. Mater. Interfaces 9, 25481–25487 (2017). (IF 8.456) PDF
7. Li, B., Zhang, X. and Dong, Y. Nanoscale platforms for messenger RNA delivery. WIREs Nanomed. Nanobiotechnol. 6, e1530 (2018). (IF 6.140) PDF
8. Li, B., Liu, X.J., Li, L., Zhang, S.H., Li, Y ., Li, D.D., and Zhen, Y .S. A tumortargeting dextran–apoprotein conjugate integrated with enediyne chromophore shows highly potent antitumor efficacy. Polym. Chem. 5, 5680–5688 (2014). (IF 4.760) PDF
9. Li, B., Luo, X., and Dong, Y. Effects of chemically modified messenger RNA on protein expression. Bioconjug Chem. 27, 849–853 (2016). (IF 4.349) PDF
11. Li, B., Zheng, Y .B., Li, D.D., and Zhen, Y .S. Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein. J Pharm Sci. 103, 1204–1213 (2014). (IF 3.197) PDF
12. Li, B., Zhao, W., Zhang, X., Wang, J., Luo, X., Baker, S.D., Jordan, C.T., and Dong, Y. Design, synthesis and evaluation of anti-CD123 antibody drug conjugates. Bioorg. Med. Chem. 24, 5855–5860 (2016). (IF 2.802) PDF
13. Li, B., Chen, G., Bai, J., Jing, Y.K. and Pei, Y .H. A bisamide and four diketopiperazines from a marine-derived Streptomyces sp. J Asian Nat Prod Res. 13, 1146–1150 (2011). (IF 1.170) PDF
14. Zhang, X.1, Zhao, W.1, Li, B., Li, W., Zhang, C., Hou, X., Jiang, J. and Dong Y. Ratiometric fluorescent probes for capturing endogenous hypochlorous acid in the lungs of mice. Chem. Sci. 9, 8207-8212 (2018). (IF 9.556) PDF
15. Luo, X., Zhao, W., Li, B., Zhang, X., Zhang, C., Bratasz, A. Deng, B. David W. McComb, D.W., and Dong Y. Co-delivery of mRNA and SPIONs through aminoester nanomaterials. Nano Res. 11, 5596-5603 (2018). (IF 8.515). PDF
16. Zhang, C.1, Zhang, X.1, Zhao, W.1, Zeng, C., L, W., Li, B., Luo, X., Li, J., Jiang, J., Binbin Deng, B., McComb, D.W. and Dong Y. Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer. Nano Res. (2019). (IF 8.515). PDF
17. Luo, X., Li, B., Zhang, X., Zhao, W., Bratasz, A., Deng, B., McComb, D.W., and Dong, Y. Dual-functional Lipid-like Nanoparticles for Delivery of mRNA and MRI Contrast Agent. Nanoscale 9, 1575–1579 (2017). (IF 6.970). PDF
18. Wang, J., Li, B., Zhao, W., Zhang, X., Luo, X., Corkins, M.E., Cole, S.L., Wang, C., Xiao, Y ., Bi, X., Pang, Y ., McElroy, C.A., Bird, A.J., and Dong, Y. Two-photon near infrared fluorescent turn-on probe toward cysteine and its imaging applications, ACS Sens. 1, 882–887 (2016). (IF 6.944) PDF
19. Zhang, X.1, Chen, X.1, Zhao, W., Zeng, C., Li, B., Jiang, J., and Dong, Y. GlcNAc conjugated atorvastatin with enhanced water solubility and cellular internalization. Bioconjug Chem. 28, 2109–2113 (2017). (IF 4.349) PDF
20. Zhao, W., Zhang, C., Li, B., Zhang, X., Luo, X., Zeng, C., Li, W., Gao, M. and Dong Y. Lipid Polymer Hybrid Nanomaterials for mRNA Delivery. Cel. Mol. Bioeng. 11, 397-406 (2018). (IF 2.477) PDF
21. 李斌,郑艳波,李良,甄永苏.基于抗体和配体的肿瘤靶向肽药物研究进展[J].中国医药生物技术. 9, 294–299 (2014). PDF
22. 李斌,陈刚,白皎,裴月湖.海洋放线菌Streptomyces sp.次级代谢产物的研究[J].中国药物化学杂志. 21, 227–231 (2011). PDF
Book Chapter:
1. Li B., Dong Y. (2017) Preparation and Optimization of Lipid-Like Nanoparticles for mRNA Delivery. In: Bindewald E., Shapiro B. (eds) RNA Nanostructures. Methods in Molecular Biology, vol 1632. Humana Press, New York, NY. PDF